Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL3172625 | 1.00 | CA12 (0.33) | CA12CA7CA9CA14 | |
| Trifluoromethanesulfonic Acid SCHEMBL3172629 | 0.98 | CA12 (0.30) | CA12CA7CA9CA14 | |
| Trifluoromethanesulfonic Acid SCHEMBL3170682 | 0.98 | CA12 (0.30) | CA12CA7CA9CA14 | |
| Trifluoromethanesulfonic Acid SCHEMBL27554652 | 0.96 | CA12 (0.33) | CA12CA7CA9CA14 | |
| Trifluoromethanesulfonic Acid SCHEMBL1450841 | 0.96 | CA12 (0.33) | CA12CA7CA9CA14 | |
| Trifluoromethanesulfonic Acid SCHEMBL949646 | 0.84 | CA12 (0.31) | CA12CA7CA9CA14 | |
| Trifluoromethanesulfonic Acid SCHEMBL1451404 | 0.82 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL2998736 | 0.81 | ALDH1A1 (0.30) | — | |
| Trifluoromethanesulfonamide SCHEMBL28747017 | 0.81 | CA1 (0.48) | CA7 | |
| Trifluoromethanesulfonic Acid SCHEMBL28748998 | 0.81 | ALDH1A1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4612126-A1 | COMPOSITIONS INCLUDING A MIXTURE OF ISOMERS OF ITACONIMIDE NORBORNENE AND CITRACONIMIDE NORBORNENE | 3M Innovative Properties Company (US) | 2025-09-10 | — | — | EP | disclosed |
| CN-120152955-A | Compositions comprising isomer mixtures of itaconimide norbornene and citraconimide norbornene | 3M创新有限公司 | 2025-06-13 | — | — | CN | disclosed |
| US-12180385-B2 | Shelf life stable and improved mass polymerizable polycyclic-olefinic compositions | PROMERYS, LLC (US) | 2024-12-31 | — | — | US | disclosed |
| US-20240279251-A1 | Monomer, Polymerizable Composition, and Polymers Derived Therefrom | 3M INNOVATIVE PROPERTIES COMPANY | 2024-08-22 | — | — | US | disclosed |
| WO-2024095078-A1 | COMPOSITIONS INCLUDING A MIXTURE OF ISOMERS OF ITACONIMIDE NORBORNENE AND CITRACONIMIDE NORBORNENE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2024-05-10 | — | — | WO | disclosed |
| US-20240002586-A1 | CURABLE COMPOSITIONS, COMPOSITE FOAM, METHOD OF MAKING THE SAME, AND ARTICLE INCLUDING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY | 2024-01-04 | — | — | US | disclosed |
| EP-4237461-A1 | SHELF LIFE STABLE AND IMPROVED MASS POLYMERIZABLE POLYCYCLIC-OLEFINIC COMPOSITIONS | Promerus, LLC (US) | 2023-09-06 | — | — | EP | disclosed |
| CN-116490538-A | Curable composition, syntactic foam, method of preparing syntactic foam, and article comprising syntactic foam | 3M创新有限公司 | 2023-07-25 | — | — | CN | disclosed |
| WO-2022238774-A1 | MONOMER, POLYMERIZABLE COMPOSITION, AND POLYMERS DERIVED THEREFROM | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-11-17 | — | — | WO | disclosed |
| US-20220135832-A1 | SHELF LIFE STABLE AND IMPROVED MASS POLYMERIZABLE POLYCYCLIC-OLEFINIC COMPOSITIONS | PROMERUS, LLC (US) | 2022-05-05 | — | — | US | disclosed |
| WO-2022094236-A1 | SHELF LIFE STABLE AND IMPROVED MASS POLYMERIZABLE POLYCYCLIC-OLEFINIC COMPOSITIONS | PROMERUS, LLC (US) | 2022-05-05 | — | — | WO | disclosed |
| EP-2039708-A1 | CYCLIC OLEFIN ADDITION COPOLYMER, METHOD FOR PRODUCING THE SAME, AND RETARDATION FILM OBTAINED FROM THE COPOLYMER | JSR Corporation (JP) | 2009-03-25 | — | — | EP | disclosed |
| US-7482412-B2 | Process for manufacturing cycloolefin addition polymer | JSR CORPORATION (JP) | 2009-01-27 | — | — | US | disclosed |
| US-20080085979-A1 | PROCESS FOR MANUFACTURING CYCLOOLEFIN ADDITION POLYMER | JSR CORPORATION (JP) | 2008-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240279251-A1 | Monomer, Polymerizable Composition, and Polymers Derived Therefrom | PBRM1, CARM1, WASF2 | CA12 1447/4885CA7 2978/4885CA9 3988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.